Two Birds with One Stone: Drug Regime Targets Viral Pathogenesis Phases and COVID-19 ARDS at the Same Time.

Ghazaleh GhavamiSoroush Sardari

Published in: Infectious disorders drug targets (2024)

In the current study, drug repurposing and high throughput docking methods have been employed to develop combination drug regimens as multiple-molecule drugs for the therapy of COVID-19 and ARDS based on a multiple-target therapy strategy. This approach offers a promising avenue for the treatment of COVID-19 and ARDS, and highlights the potential benefits of drug repurposing in the fight against the current pandemic.

Keyphrases

sars cov
coronavirus disease
acute respiratory distress syndrome
high throughput
extracorporeal membrane oxygenation
mechanical ventilation
adverse drug
drug induced
molecular dynamics
emergency department
single cell
intensive care unit
risk assessment
climate change
cell therapy
small molecule